Bio-Rad Laboratories (NYSE:BIO.B) Sees Large Volume Increase – Still a Buy?

Bio-Rad Laboratories, Inc. (NYSE:BIO.B) shares saw an uptick in trading volume on Wednesday . 218 shares were traded during trading, a decline of 22% from the previous session’s volume of 280 shares.The stock last traded at $359.22 and had previously closed at $357.05.

Bio-Rad Laboratories Trading Up 0.2 %

The firm has a market cap of $10.01 billion, a price-to-earnings ratio of -13.09 and a beta of 0.72. The firm’s 50-day moving average is $336.01 and its 200-day moving average is $328.84. The company has a current ratio of 6.14, a quick ratio of 4.52 and a debt-to-equity ratio of 0.16.

Bio-Rad Laboratories (NYSE:BIO.B) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $2.01 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a negative net margin of 30.18% and a positive return on equity of 3.74%. The firm had revenue of $649.73 million during the quarter.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.